Introduction: Infections in solid organ transplantation

American Journal of Transplantation

Volumn 13, Issue SUPPL.4, 2013, Pages 3-8

  Green, M ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

donor derived infection; immunosuppression; opportunistic infection; transplant infectious disease

Indexed keywords

ARTICLE; ATTRIBUTABLE RISK; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CLINICAL DECISION MAKING; COMORBIDITY; CYTOMEGALOVIRUS INFECTION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; EPSTEIN BARR VIRUS INFECTION; GRAFT INFECTION; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS C; HOSPITAL INFECTION; HUMAN; IMMUNOPATHOGENESIS; INFECTION RISK; INTRAOPERATIVE PERIOD; LUNG GRAFT REJECTION; MORTALITY; ORGAN TRANSPLANTATION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SOLID ORGAN TRANSPLANTATION; SURGICAL INFECTION; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

HUMANS; INFECTION; ORGAN TRANSPLANTATION; TISSUE DONORS;

EID: 84874906669     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12093     Document Type: Article

References (32)

1. Dummer JS, Hardy A, Poorsattar A, et al. Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation 1983; 36: 259-267.
2. Ho M, Dummer JS,. Risk factors and approaches to infection in transplant recipients. In:, Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and Practice of Infectious Diseases. New York, Churchill Livingstone, 1990, p 2294.
3. Cuervas-Mons V, Rimola A, Van Thiel DH, et al. Does previous abdominal surgery alter the outcome of pediatric patients subjected to orthotopic liver transplantation ? Gastroenterology 1986; 90: 853-857.
4. Hsu J, Griffith BP, Dowling RD, et al. Infections in mortally ill cardiac transplant recipients. J Thorac Cardiovasc Surg 1989; 98: 506-509.
5. Their M, Holmberg C, Lautenschlager I, et al. Infections in pediatric kidney and liver transplant patients after perioperative hospitalization. Transplantation 2000; 69: 1617-1623.
6. Breinig MK, Zitelli B, Starzl TE, et al. Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation. J Infect Dis 1987; 156: 273-279.
7. Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988; 45: 719-727.
8. Gelson W, Hoare M, Vowler S, et al. Features of immune senescence in liver transplant recipients with established grafts. Liver Transplant 2010; 16: 577-87.
9. Meier-Kriesche H, Friedman G, Jacobs M, Mulgaonkar S, Vaghela M, Kaplan B,. Infectious complications in geriatric renal transplant recipients: Comparison of two immunosuppressive protocols. Transplantation 1999; 68: 1496-1502.
10. Burroughs M, Moscona A,. Immunization of pediatric solid organ transplant candidates and recipients. Clin Infect Dis 2000; 30: 857-869.
11. Green M, Wald ER, Fricker FJ, et al. Infections in pediatric orthotopic heart transplant recipients. Pediatr Infect Dis J 1989; 8: 87-93.
12. Dummer JS, White LT, Ho M, et al. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis 1985; 152: 1182-1191.
13. Bowman JS, Green M, Scantlebury VP,. OKT3 and viral disease in pediatric liver transplant recipients. Clin Transplant 1991; 5: 294-300.
14. Ison MG, Hager J, Blumberg E, et al. Donor-derived disease transmission events in the United States: Data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant 2009; 9: 1929-1935.
15. Zenati M, Dowling RD, Dummer JS, et al. Influence of the donor lung on development of early infections in lung transplant recipients. J Heart Transplant 1990; 9: 502-508.
16. Kusne S, Dummer JS, Singh N, et al. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine 1988; 67: 132-143.
17. Ferdinande P, Bruyninclox F, Van Raemdonck D, Daenen W, Verleden G, Leuven L,. Phrenic nerve dysfunction after heart-lung and lung transplantation. J Heart Lung Transplant 2004; 23: 105-109.
18. Koo S, Marty FM, Baden LR,. Infectious complications associated with immunomodulating biologic agents. Inf Dis Clin N Am 2010; 24: 285-306.
19. Humar A, Michaels M, AST ID Working Group on Infectious Disease Monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant. 6: 262-274, 2006
20. Schroter GP, Hoelscher M, Putnam CW, et al. Infections complicating orthotopic liver transplantation: A study emphasizing graft-related septicemia. Arch Surg 1976; 111: 1337-1347.
21. Hanevold CD, Kaiser BA, Palmer J., Vesicoureteral reflux and urinary tract infections in renal transplant recipients. Am J Dis Child 1987; 141: 982-984.
22. Al-Hasana B, Razonableb RR, Eckel-Passowd JE, Baddourb LM,. Incidence rate and outcome of Gram-negative bloodstream infections in solid organ transplant recipients. Am J Transplant 2009; 9: 835-843.
23. Green M, Michaels MG, Webber SA, et al. The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients. Pediatr Transplant 1999; 3: 271-281.
24. Paya CV, Fung JJ, Nalesnik MA, et al. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation 1999; 68: 1517-1525.
25. Hardy AM, Wajszczuk CP, Suffredini AF, et al. Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids. J Infect Dis 1984; 149: 143-147.
26. Schafers HJ, Cremer J, Wahlers T, et al. Pneumocystis carinii pneumonia following heart transplantation. Eur J Cardiothorac Surg 1987; 1: 49-52.
27. Gryzan S, Paradis IL, Zeevi A, et al. Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. Am Rev Respir Dis 1988; 137: 1268-1274.
28. Luft BJ, Naot Y, Araujo FG, et al. Primary and reactivated toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population. Ann Intern Med 1983; 99: 27-31.
29. Kaditis AG, Phadke S, Dickman P, et al. Mortality after pediatric lung transplantation: Autopsies vs. clinical impression. Pediatr Pulmonol 2004; 37: 413-418.
30. Sims KD, Blumberg EA,. Common infections in lung transplant recipients. Clin Chest Med 2011; 32: 327-341.
31. Humar A, Snydman D, and the AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S78-S86.
32. Levitsky J, Kalil AC, Meza JL, Hurst GE, Friefeld A, Chicken pox after pediatric liver transplantation. Liver Transplant 2005; 11: 1563-1566.